Literature DB >> 27080029

Australia's notifiable disease status, 2014: Annual report of the National Notifiable Diseases Surveillance System.

.   

Abstract

In 2014, 69 diseases and conditions were nationally notifiable in Australia. States and territories reported a total of 275,581 notifications of communicable diseases to the National Notifiable Diseases Surveillance System, an increase of 22% on the number of notifications in 2013. In 2014, the most frequently notified diseases were sexually transmissible infections (105,719 notifications, 38% of total notifications), vaccine preventable diseases (101,400 notifications, 37% of total notifications), and gastrointestinal diseases (40,367 notifications, 15% of total notifications). There were 17,411 notifications of bloodborne diseases; 8,125 notifications of vectorborne diseases; 1,942 notifications of other bacterial infections; 615 notifications of zoonoses and 2 notifications of quarantinable diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27080029

Source DB:  PubMed          Journal:  Commun Dis Intell Q Rep        ISSN: 1447-4514


  16 in total

1.  Burden of Disease Attributed to Waterborne Transmission of Selected Enteric Pathogens, Australia, 2010.

Authors:  Katherine B Gibney; Joanne O'Toole; Martha Sinclair; Karin Leder
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

Review 2.  As through a glass, darkly: the future of sexually transmissible infections among gay, bisexual and other men who have sex with men.

Authors:  Mark Richard Stenger; Stefan Baral; Shauna Stahlman; Dan Wohlfeiler; Jerusha E Barton; Thomas Peterman
Journal:  Sex Health       Date:  2017-02       Impact factor: 2.706

3.  Legionellosis and Recent Advances in Technologies for Legionella Control in Premise Plumbing Systems: A Review.

Authors:  Kelsie M Carlson; Laura A Boczek; Soryong Chae; Hodon Ryu
Journal:  Water (Basel)       Date:  2020-03-02       Impact factor: 3.103

4.  Legionella longbeachae detected in an industrial cooling tower linked to a legionellosis outbreak, New Zealand, 2015; possible waterborne transmission?

Authors:  C N Thornley; D J Harte; R P Weir; L J Allen; K J Knightbridge; P R T Wood
Journal:  Epidemiol Infect       Date:  2017-06-19       Impact factor: 4.434

5.  Draft Genome Sequence of the First Confirmed Isolate of Multidrug-Resistant Mycobacterium tuberculosis in Tasmania.

Authors:  Sanjay S Gautam; Micheál Mac Aogáin; Ronan F O'Toole
Journal:  Genome Announc       Date:  2017-11-02

Review 6.  National Communicable Disease Surveillance System: A review on Information and Organizational Structures in Developed Countries.

Authors:  Hossein Bagherian; Mohammad Farahbakhsh; Reza Rabiei; Hamid Moghaddasi; Farkhondeh Asadi
Journal:  Acta Inform Med       Date:  2017-12

7.  Molecular epidemiology of tuberculosis in Tasmania and genomic characterisation of its first known multi-drug resistant case.

Authors:  Sanjay S Gautam; Micheál Mac Aogáin; Louise A Cooley; Greg Haug; Janet A Fyfe; Maria Globan; Ronan F O'Toole
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

8.  Hospital based surveillance of congenital rubella syndrome cases in the pre-vaccine era in Amhara Regional State, Ethiopia: A base line information for the country.

Authors:  Yitayih Wondimeneh; Moges Tiruneh; Getachew Ferede; Kassahun Denekew; Fisseha Admassu; Belay Tessema
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

Review 9.  Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis.

Authors:  Madhur D Shastri; Shakti Dhar Shukla; Wai Chin Chong; Kamal Dua; Gregory M Peterson; Rahul P Patel; Philip M Hansbro; Rajaraman Eri; Ronan F O'Toole
Journal:  Oxid Med Cell Longev       Date:  2018-10-11       Impact factor: 6.543

10.  Ascertaining infectious disease burden through primary care clinic attendance among young Aboriginal children living in four remote communities in Western Australia.

Authors:  David Hendrickx; Asha C Bowen; Julie A Marsh; Jonathan R Carapetis; Roz Walker
Journal:  PLoS One       Date:  2018-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.